ArticleScientific reports2025
Automated skin cancer detection using MedFusionNet with attention-based fusion of ConvNeXt and vision transformer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From intelligent models to clinical tools: the evolving landscape of AI in medical imaging.Scientific reports · 2026Article
- A hybrid approach for accurate skin lesion segmentation using LEDNet and Swin-UMamba.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer, especially melanoma, the most severe type, has increased in recent decades. It develops from cells that grow abnormally and can invade the surrounding tissue and spread throughout the body. Early and accurate diagnosis is essential to prevent disease progression and allow for less invasive clinical treatment. The extraction of complex dermoscopic images and the improvement of lesion classification performance have significantly improved skin cancer diagnosis through the use of convolutional neural networks (CNNs). In this study, a novel deep convolutional neural network that combines ConvNeXt and Vision Transformer (ViT) architectures through an adaptive attention-based approach for advanced feature fusion to automatically multi-classify skin cancer samples. This model is evaluated on two dermoscopy benchmark datasets, including ISIC-2019 and HAM10000 and both datasets reflect the real-world problem of class imbalance. The evaluation results of MedFusionNet are calculated using various evaluation metrics, including accuracy, precision, recall and AUC and compared with deep learning algorithms such as ResNet50, MobileNet V2, DenseNet121 and ViT-B16. The experimental results show that MedFusionNet outperforms the current models with a classification accuracy of 98.80% and 97.90% for HAM10000 and ISIC-2019, respectively. Grad-CAM visualizations qualitatively show that the model focuses on clinically relevant lesion regions, providing interpretive insight without claiming complete causal explainability. The results show that the proposed model can efficiently handle multi-class tasks in dermatological imaging and MedFusionNet is a suitable choice for implementation in real-world computer-aided diagnosis systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.